top of page

Celligenics Signs MOU With Series A Investor Best World International (April 2021)

Celligenics is pleased to announce that we have signed a Memorandum of Understanding (MOU) with our Series A investor, Best World International (BWI), and we look forward to the next stage of our strategic partnership, as we move closer towards the development and launch of our next generation of stem cell-based healthcare and wellness products.



Related Posts

See All

Comments


bottom of page